Prevalence of Diagnosed Cancer According to Duration of Diagnosed Diabetes and Current Insulin Use Among U.S. Adults With Diagnosed Diabetes: Findings from the 2009 Behavioral Risk Factor Surveillance System

• Autores: Chaoyang Li, Guixiang Zhao, Catherine A. Okoro, Xiao-Jun Wen, Earl S. Ford
• Localización: Diabetes care, ISSN-e 0149-5992, Vol. 36, Nº. 6, 2013, págs. 1569-1576
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • OBJECTIVE-To estimate the prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among U.S. adults with diagnosed diabetes.

    RESEARCH DESIGN AND METHODS-We analyzed data from 25,964 adults aged =18 years with diagnosed diabetes who participated in the 2009 Behavioral Risk Factor Surveillance System.

    RESULTS-After adjustment for potential confounders, we found that the greater the duration of diagnosed diabetes, the higher the prevalence of diagnosed cancers (P < 0.0001 for linear trend). Among adults with diagnosed type 2 diabetes, the prevalence estimate for cancers of all sites was significantly higher among men (adjusted prevalence ratio 1.6 [95%C1 1.3-1.9]) and women (1.8 [1.5-2.1)) who reported being diagnosed with diabetes =15 years ago than among those reporting diabetes diagnosis <15 years ago. The prevalence estimate for cancers of all sites was ~1.3 times higher among type 2 diabetic adults who currently used insulin than among those who did not use insulin among both men (1.3 [1.1-1.6]) and women (1.3 [1.1-1.51).

    CONCLUSIONS-Our results suggest that there is an increased burden of diagnosed cancer among adults with a longer duration of diagnosed diabetes and among type 2 diabetic adults who currently use insulin.